Cancer treatment by telomerase inhibitors: Predictions by a kinetic model

Mathematical Biosciences

Volumn 181, Issue 2, 2003, Pages 209-221

  Sidorov, Igor A ^a   Hirsch, Ken S ^b   Harley, Calvin B ^c   Dimitrov, Dimiter S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Emergent Biotechnologies LLC   (United States)

^c GERON CORPORATION   (United States)

Author keywords

Kinetic model; Telomerase inhibitors; Telomere

Indexed keywords

DIFFERENTIAL EQUATIONS; DNA; ENZYMES;

TELOMERASE INHIBITORS;

TUMORS;

DNA; TELOMERASE INHIBITOR;

CANCER; ENZYME ACTIVITY;

ARTICLE; CANCER THERAPY; CELL DIVISION; CELL GROWTH; DRUG EFFICACY; KINETICS; MATHEMATICAL MODEL; TELOMERE;

CELL DIVISION; COMPUTER SIMULATION; FORECASTING; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; TELOMERASE; TIME FACTORS;

EID: 0346666718     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(02)00132-3     Document Type: Article

References (27)

1. E.H. Blackburn, Structure and function of telomeres, Nature 350 (1991) 569.
2. C.W. Greider, Telomere length regulation, Biochemistry 65 (1996) 337.
3. N.W. Kim, M.A. Piatyszek, K.R. Prowse, C.B. Harley, M.D. West, P.L.C. Ho, G.M. Coviello, W.E. Wright, S.L. Weinrich, J.W. Shay, Specific association of human telomerase activity with immortal cells and cancer, Science 266 (1994) 2011.
4. J.W. Shay, S.A. Bacchetti, A survey of telomerase activity in human cancer, Eur. J. Cancer 33 (1997) 787.
5. W.C. Hahn, S.A. Stewart, M.W. Brooks, S.G. York, E. Eaton, A. Kurachi, R.L. Beijersbergen, J.H.M. Knoll, M. Meyerson, R.A. Weinberg, Inhibition of telomerase limits the growth of human cancer cells, Nature Medicine 5 (1999) 1164.
6. L.A. Zumstein, V. Lundblad, Telomeres: Has cancer's Achilles' hell been exposed?, Nature Medicine 5 (1999) 1129.
7. J.W. Shay, Toward identifying a cellular determinant of telomerase repression, J. Nat. Cancer Inst. 91 (1999) 4.
8. C.B. Harley, N.W. Kim, K.R. Prowse, S.L. Weinrich, K.S. Hirsh, M.D. West, S.A. Bacchetti, H.W. Hirte, C.M. Counter, C.W. Greider, et al., Telomerase cell immortality and cancer, Cold. Spring. Harb. Symp. Quant. Biol. 59 (1994) 307.
9. A.P. Cuthbert, J. Bond, D.A. Trott, S. Gill, J. Broni, A. Mariott, G. Khoudoli, E.K. Parkinson, C. Cooper, R. Newbold, Telomerase repressor sequemces on chromosome 3 and induction of permanent growth arrest in human breast cancer cells, J. Nat. Cancer Inst. 91 (1999) 37.
10. M.G. Butler, M. Sciadini, L.K. Hedges, H.S. Schwartz, Chromosome telomere integrity of human solid neoplasms, Cancer Genet. Cytogen. 86 (1996) 50.
11. M.A. Shammas, C.G. Simmons, D.R. Corey, R.J. Shmookler Reis, Telomerase inhibition by peptide nucleic acids revers 'immortality' of transformed human cells, Oncogene 18 (1999) 6191.
12. C.M. Counter, A.A. Avilion, C.E. LeFeuvre, N.G. Stewart, C.W. Greider, C.B. Harley, S.A. Bacchetti, Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity, EMBO J. 11 (1992) 1921.
13. R.C. Allsopp, H. Vaziri, C. Patterson, S. Goldstein, E.V. Younglai, A.B. Futcher, C.W. Greider, C.B. Harley, Telomere length predicts replicative capacity of human fibroblasts, Proc. Nat. Acad. Sci. USA 82 (1992) 10114.
14. C.B. Harley, A.B. Futcher, C.W. Greider, Telomeres shorten during ageing of human fibroblasts, Nature 345 (1990) 458.
15. N. Weng, B.L. Levine, C.H. June, R.J. Hodes, Human naive and memory T lymphocytes differ in telomeric length and replicative potential, Proc. Nat. Acad. Sci. USA 92 (1995) 11091.
16. X. Zhang, V. Mar, W. Zhou, L. Harrington, M.O. Robinson, Telomere shortening and apoptosis in telomerase-inhibited human tumor cells, Genes and Development 13 (1999) 2388.
17. M. Schwartz, A biomathematical approach to clinical tumor growth, Cancer 14 (1961) 1272.
18. M. Marusic, Z. Bajzer, S. Vuk-Pavlovic, Tumor growth in vivo and as multicellular spheroids compared by mathematical models, Bull. Math. Biol. 56 (1994) 617.
19. V.G. Vaidya, F.J. Alexandro Jr., Evaluation of some mathematical models for tumor growth, Int. J. Bio-Med. Comp. 13 (1982) 19.
20. A.K. Laird, Dynamics of tumor growth, Br. J. Cancer. 18 (1964) 490.
21. D.J. Adamson, D.J. King, N.E. Haites, Significant telomere shortening in childhood leukemia, Cancer Genet. Cytogen 61 (1992) 204.
22. P. Nurnberg, G. Thiel, F. Weber, J.T. Epplen, Changes of telomere lengths in human intracranial tumors, Human Genet. 90 (1993) 190.
23. G.T. Huang, H.S. Lee, C.H. Chen, L.L. Chiou, Y.W. Lin, C.Z. Lee, D.S. Chen, J.C. Sheu, Telomerase activity and telomere length in human hepatocellular carcinoma, Eur. J. Cancer 34 (1998) 1946.
24. K. Remes, K.F. Norrback, R. Rosenquist, C. Mehle, J. Lindh, G. Roos, Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse, Br. J. Cancer 82 (2000) 601.
25. E. Hiyama, T. Yakoyama, K. Hiyama, M. Yamakido, T. Santo, T. Kodama, T. Ichikawa, Y. Matsuura, Alteration of telomeric repeat length in adult and childhood solid neoplasias, Int. J. Oncology 6 (1995) 13.
26. O.E. Bechter, W. Eisterer, G. Pall, W. Hilbe, T. Kuhr, J. Thaler, Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia, Cancer Res. 58 (1998) 4918.
27. J. Albanell, F. Lonardo, V. Rush, M. Engelhardt, J. Langenfeld, W. Han, D. Klimstra, V. Venkatraman, M.A.S. Moore, E. Dmitrovsky, High telomerase activity in primary lung cancer: Association with increased cell proliferation rates and advanced pathologic stage, J. Nat. Cancer. Inst. 89 (1997) 1609.